Loading clinical trials...
Loading clinical trials...
A Phase 1, Open-Label, Randomized, Crossover Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vonoprazan (20 mg) and Lansoprazole (30 mg) in Healthy Subjects
Conditions
Interventions
Vonoprazan
Lansoprazole
Locations
1
United States
Celerion, 2420 W Baseline Rd,
Tempe, Arizona, United States
Start Date
January 28, 2021
Primary Completion Date
June 12, 2021
Completion Date
June 26, 2021
Last Updated
March 31, 2023
NCT07310901
NCT06342713
NCT07401472
NCT07412353
NCT07280858
NCT07300189
Lead Sponsor
Phathom Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions